L-cystathionine inhibits oxidized low density lipoprotein-induced THP-1-derived macrophage inflammatory cytokine monocyte chemoattractant protein-1 generation via the NF-κB pathway

Sci Rep. 2015 May 28:5:10453. doi: 10.1038/srep10453.

Abstract

This study aimed to explore whether and how L-cystathionine had any regulatory effect on the inflammatory response in THP-1-derived macrophages cultured in vitro under oxidized low-density lipoprotein (ox-LDL) stimulation. The human monocyte line THP-1 cell was cultured in vitro and differentiated into macrophages after 24 hours of PMA induction. Macrophages were pretreated with L-cystathionine and then treated with ox-LDL. The results showed that compared with the controls, ox-LDL stimulation significantly upregulated the expression of THP-1-derived macrophage MCP-1 by enhancing NF-κB p65 phosphorylation, nuclear translocation and DNA binding with the MCP-1 promoter. Compared with the ox-LDL group, 0.3 mmol/L and 1.0 mmol/L L-cystathionine significantly inhibited the expression of THP-1-derived macrophage MCP-1. Mechanistically, 0.3 mmol/L and 1.0 mmol/L L-cystathionine suppressed phosphorylation and nuclear translocation of the NF-κB p65 protein, as well as the DNA binding activity and DNA binding level of NF-κB with the MCP-1 promoter, which resulted in a reduced THP-1-derived macrophage MCP-1 generation. This study suggests that L-cystathionine could inhibit the expression of MCP-1 in THP-1-derived macrophages induced by ox-LDL via inhibition of NF-κB p65 phosphorylation, nuclear translocation, and binding of the MCP-1 promoter sequence after entry into the nucleus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects
  • Cystathionine / administration & dosage
  • Humans
  • Inflammation / drug therapy
  • Inflammation / genetics
  • Inflammation / pathology
  • Lipoproteins, LDL / administration & dosage
  • Lipoproteins, LDL / metabolism
  • Macrophage Inflammatory Proteins / genetics*
  • Macrophage Inflammatory Proteins / metabolism
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Macrophages / pathology
  • Monocytes / drug effects
  • Monocytes / metabolism
  • Phosphorylation / drug effects
  • Transcription Factor RelA / biosynthesis*
  • Transcription Factor RelA / genetics

Substances

  • Lipoproteins, LDL
  • Macrophage Inflammatory Proteins
  • Transcription Factor RelA
  • oxidized low density lipoprotein
  • Cystathionine